Related Experiment Video
Updated: Jan 14, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Extrachromosomal circular DNA promotes inflammation and hepatocellular carcinoma development
Lap Kwan Chan1,2, Juanjuan Shan1,2,3, Elias Rodriguez-Fos4
1Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland.
Micronuclei in liver cells release extrachromosomal circular DNA (eccDNA), triggering immune responses that drive liver cancer. Blocking the cGAS-STING pathway reduces tumor development in chronic liver disease models.
Area of Science:
- Hepatology
- Cancer Biology
- Immunology
Background:
- Micronuclei and extrachromosomal circular DNA (eccDNA) are observed in chronic liver disease (CLD) and hepatocellular carcinoma (HCC).
- The precise role of micronuclei in HCC development remains unclear.
- Understanding the mechanisms linking liver disease, micronuclei, and cancer is crucial for therapeutic strategies.
Purpose of the Study:
- To investigate the role of micronuclei and eccDNA in promoting HCC development.
- To elucidate the molecular mechanisms by which micronuclei influence hepatic immune responses and carcinogenesis.
- To explore the potential of targeting the cGAS-STING pathway in liver cancer prevention.
Main Methods:
- Development of the nuclei-segregated DNA fiber (NuSeF) assay to analyze DNA replication stress in micronuclei.
- Circular sequencing to quantify eccDNA levels in micronuclei and nuclei.
- Utilizing a CLD mouse model (Mcl1Δhep) and comparing it with other murine liver disease models.
- Genetic deletion of Sting1 in the CLD model to assess the role of the cGAS-STING pathway.
Main Results:
- Increased micronuclei and eccDNA levels were observed in the livers of CLD model mice.
- Micronuclei showed higher susceptibility to replication stress, leading to replication fork slowing.
- Higher eccDNA levels correlated with increased tumor incidence across different liver disease models.
- eccDNA acted as an immunostimulant, promoting hepatocyte-immune cell crosstalk via the cGAS-STING pathway.
- Deletion of Sting1 significantly reduced immune cell chemotaxis and liver tumor incidence.
Conclusions:
- Micronuclei-derived eccDNA triggers hepatic immune responses that promote inflammation-driven liver carcinogenesis in CLD.
- The cGAS-STING pathway is a key mediator of eccDNA-induced liver inflammation and tumor development.
- Targeting eccDNA and the cGAS-STING pathway presents a potential therapeutic strategy for preventing HCC in CLD patients.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
Somatic...
Inheritance of Chromatin Structures
Non-LTR Retrotransposons
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Mechanisms of Retrovirus-induced Cancers

